From: The impact of intravenous iron supplementation in elderly patients undergoing major surgery
 |  | A− (n = 1,364) | A−, ID+, T+ (n = 36) | A+ (n = 576) | A+, ID+, T+ (n = 215) |
---|---|---|---|---|---|
Age | 73.6 (± 5.8) | 74 (± 5.4) | 75.1 (± 6.2) | 76.3 (± 6.3) | |
Gender (female) | 28.4% (n = 388) | 54.1% (n = 20) | 25.5% (n = 150) | 42.6% (n = 95) | |
BMI | 27.1 (± 4.8) | 24.6 (± 4.7) | 26.4 (± 5.1) | 26.5 (± 4.6) | |
ASA | I-II | 17.9% (n = 244) | 21.6% (n = 8) | 6.8% (n = 39) | 6.9% (n = 15) |
 | III-IV | 81.9% (n = 1,117) | 78.4% (n = 28) | 92.3% (n = 532) | 92.2% (n = 198) |
 | V | 0.2% (n = 3) | 0% (n = 0) | 0.9% (n = 5) | 0.9% (n = 2) |
Surgical discipline | Â | Â | Â | Â | |
 | Cardiac thoracic surgery | 52.3% (n = 713) | 37.8% (n = 13) | 44.7% (n = 258) | 36.3% (n = 78) |
 | Urology | 17.8% (n = 243) | 13.5% (n = 5) | 8.0% (n = 46) | 7.2% (n = 16) |
 | Vascular surgery | 13.3% (n = 181) | 13.5% (n = 5) | 20.7% (n = 119) | 25.1% (n = 54) |
 | Visceral surgery | 11.7% (n = 160) | 24.3% (n = 9) | 21.9% (n = 126) | 27.8% (n = 60) |
 | Maxillofacial surgery | 4.4% (n = 60) | 10.8% (n = 4) | 2.0% (n = 12) | 3.1% (n = 6) |
 | Orthopaedic/trauma surgery | 0.4% (n = 6) | 0% (n = 0) | 2.4% (n = 14) | 0.4% (n = 1) |
 | Gynaecology | 0.1% (n = 1) | 0% (n = 0) | 0.2% (n = 1) | 0% (n = 0) |
Preoperative Hb (g/dl) a | 14.2 (± 1.1) | 13.2 (± 0.9) | 11.1 (± 1.3) | 10.6 (± 1.5) | |
 | 14.1(13.4; 14.9) | 13.2 (12.5; 13.6) | 11.3 (10.4; 12.2) | 11 (9.6; 11.8) | |
 | female | 13.4 (± 1) | 12.9 (± 0.8) | 10.6 (± 1.1) | 10.5 (± 1.4) |
 |  | 13.3 (12.7; 14) | 12.7 (12.3; 13.6) | 10.8 (10; 11.4) | 10.8 (9.6; 11.5) |
 | male | 14.5 (± 1) | 13.6 (± 0.8) | 11.3 (± 1.3) | 10.7 (± 1.5) |
 |  | 14.4 (13.7; 15.1) | 13.4 (13; 13.7) | 11.5 (10.6; 12.4) | 11.1 (9.6; 12) |